Miglustat is used to treat adults with mild-to-moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. It is marketed under the trade name Zavesca. Reference standards of Miglustat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => N-Butyldeoxynojirimycin Hydrochloride-d9 [catalogue_number] => PA STI 016160 [category_ids] => ,119,78,70,82,98, [chemical_name] => [weight] => 264.79 [form] => C10H13D9ClNO4 [cas] => 1883545-57-0 [pslug] => 1883545-57-0-n-butyldeoxynojirimycin-hydrochloride-d9-pasti016160 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 016160
CAS :
Molecular Formula : C10H13D9ClNO4
Molecular Weight : 264.79
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....